Prolastin United States
United States

 Advanced Search
Print This Page
Healthcare Professionals
Prolastin Direct

If you are considering Prolastin® for augmentation therapy call Prolastin DirectSM at 1-800-305-7881 to enroll in our unique program.



Prolastin DirectSM is a program designed to provide patients with an option to receive Prolastin® direct from Talecris when and where you need it, across the USA.

This option also offers a full range of services:

EASY enrollment
Just one phone call gets you started: 1-800-305-7881.
Insurance verification and coordination
Reimbursement experts work directly with payers on behalf of patients to verify and coordinate coverage. Less than 2% of patients referred to Prolastin Direct have been unable to get insurance coverage for Prolastin.
Infusion coordination
Care Coordinators help locate a site for all infusions and coordinate all details for the patient. All infusion nurses have access to specialized Prolastin training.
Pharmacy services
Staff of dedicated pharmacists is on call 24 hours a day, every day. Services are customized for each alpha-1 patient.
Reliable delivery
Prolastin is shipped directly to any location of care. Based on your patient’s prescribed dosage schedule, Prolastin is shipped automatically on a regular basis to ensure that your patient has the medication when he or she needs it.
Home infusion with alpha-1–certified nurses
Home infusion provided through a national network of nurses certified in alpha-1 care. Home infusion services allow for scheduling flexibility and convenience.
Health management
Education and supportive follow-up from AlphaNet Coordinators, who are alpha-1 patients themselves. The services from Prolastin Direct have been shown to reduce the frequency of exacerbations.
To enroll and learn more about Prolastin DirectSM call 1-800-305-7881.

Important Safety Information

Prolastin®, Alpha1-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha1-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Prolastin® full Prescribing Information.

Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.

How Prolastin Direct™ works to help patients get Prolastin® when and where they need it.
Prolastin® Home  |   About Prolastin®  |   About AAT Deficiency  |   Diseases Caused by AAT Deficiency   |   Living With AAT Deficiency
How to Get Prolastin®  |   Tools & Resources  |   Prescribing Information  |   For Healthcare Professionals  |   Site Map  |   Glossary



 
  Talecris Biotherapeutics   Contact Talecris    General Conditions of Use    Privacy Statement    Contact Prolastin®
 
This site is intended for US residents only. Non-US residents can go to www.Talecris.com.
© 2007 Talecris Biotherapeutics, Inc.